| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.071 | 0.02 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.02 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | 0.42 | 0.02 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.083 | 0.02 |